Financial statements Cortex Pharm
Balance sheet of Cortex Pharm
Share capital:
Share capital:
20 000 PLN
Company deleted from KRS: 2021-03-31
Balance sheet data of CORTEX PHARM
|
Year
|
2018
|
2019
|
2020
|
|---|---|---|---|
| Total assets | 10 000,00 | 12 379,99 | 12 379,99 |
| A. Fixed assets | - | 10 000,00 | 10 000,00 |
| B. Current assets | 2 379,99 | 2 379,99 | 2 379,99 |
| C. Share capital contributions (basic funds) | - | - | 0,00 |
| D. Own shares (stocks) | - | - | 0,00 |
| Total liabilities | 12 379,99 | 12 379,99 | 12 379,99 |
| A. Equity | - | 12 379,99 | 12 379,99 |
| B. Liabilities and provisions for liabilities | 0,00 | 0,00 | 0,00 |
| I. Long-term liabilities | - | - | - |
| II. Short-term liabilities | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.